These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


101 related items for PubMed ID: 233543

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Studies on the vincamine-papaverine association. IV. Interference with beta-receptors in experimental animals.
    Cattani L, Costrini R, Manani G, Galzigna L, Giron GP, Costa G, Civran E, Bossi M.
    Agressologie; 1978; 19(6):385-91. PubMed ID: 35999
    [No Abstract] [Full Text] [Related]

  • 4. [Effects of vincamine and a vincamine-papaverine combination on erythrocyte flexibility in diabetic patients].
    Petruzzi E, Bucalossi A.
    Minerva Cardioangiol; 1985 Nov; 33(11):671-3. PubMed ID: 4088469
    [No Abstract] [Full Text] [Related]

  • 5. [Effects of a vincamine-papaverine combination on platelet aggregation in geriatric patients with glucose and/or lipid metabolism disorders].
    Petruzzi E, Bucalossi A, Chiostri R.
    Minerva Cardioangiol; 1985 Sep; 33(9):561-4. PubMed ID: 4088484
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Studies on the vincamine-papaverine association. i. biochemical investigations.
    Costrini R, Galzigna L, Bianchi M, Nunziata A, Cattani L.
    Agressologie; 1978 Sep; 19(3):211-4. PubMed ID: 736220
    [No Abstract] [Full Text] [Related]

  • 9. Studies on the vincamine-papaverine association ii. acute toxicity in experimental animals as a function of the speed of infusion.
    Nunziata A, Costrini R, Mercatelli P, Perri GC.
    Agressologie; 1978 Sep; 19(3):215-9. PubMed ID: 736221
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Cerebral antioedematous effect of Teproside and of some vincamine derivatives.
    Borzeix MG, Cahn J.
    Int J Clin Pharmacol Res; 1984 Sep; 4(4):259-61. PubMed ID: 6500773
    [Abstract] [Full Text] [Related]

  • 12. [Experimental studies on the effects of vincamine and its analogues on cerebrovascular circulation].
    Imamoto T, Nukada T, Tada K.
    No To Shinkei; 1977 Mar; 29(3):341-7. PubMed ID: 558779
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Severe hypocapnia applied to study the effect of vincamine on cerebral circulation.
    Palacios L, Roca J, Balasch J.
    Arch Farmacol Toxicol; 1978 Aug; 4(2):261-4. PubMed ID: 727839
    [No Abstract] [Full Text] [Related]

  • 15. Age-dependent modification of drug interference on the enzymatic activities of the rat brain.
    Benzi G, Arrigoni E, Dagani F, Marzatico F, Curti D, Raimondo S, Dossena M, Polgatti M, Villa RF.
    Exp Gerontol; 1980 Aug; 15(6):593-603. PubMed ID: 6258955
    [No Abstract] [Full Text] [Related]

  • 16. Vincamine TPS activity on glycoconjugate metabolism of the brain: effect on lysosomal enzymes.
    Federico A, D'Amore I.
    Int J Clin Pharmacol Res; 1984 Aug; 4(4):277-9. PubMed ID: 6500774
    [Abstract] [Full Text] [Related]

  • 17. Calcium antagonistic action involved in vasodilation by brovincamine.
    Katsuragi T, Ohba M, Mori R, Kushiku K, Furukawa T.
    Gen Pharmacol; 1984 Aug; 15(1):43-5. PubMed ID: 6698382
    [Abstract] [Full Text] [Related]

  • 18. Studies on the vincamine-papaverine association iii. clinical use in cardiac patients.
    Pirani R, Cattani L, Tomasi AM, Masoni A.
    Agressologie; 1978 Aug; 19(3):221-5. PubMed ID: 736222
    [No Abstract] [Full Text] [Related]

  • 19. Electronystagmographic study in rabbits on the vestibular effect of vincamine.
    Hamann KF, Bernhold B, Sattler B, Iatraki L.
    Arzneimittelforschung; 1979 Aug; 29(1):34-8. PubMed ID: 312648
    [Abstract] [Full Text] [Related]

  • 20. A comparison of some of the pharmacological properties of the new eburnamenine derivative vindeburnol with those of vincamine, vinburnine, dihydroergotoxine mesilate and nicergoline.
    Barzaghi F, Dragonetti M, Formento ML, Gueniau C, Nencioni A, Mantegazza P.
    Arzneimittelforschung; 1986 Oct; 36(10):1442-8. PubMed ID: 3814205
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.